- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: HP6H8 | Ketantin®
Compound class: Antibody
Comment: Meplazumab is a humanized IgG2 monoclonal antibody that targets CD147 (basigin). It is being developed by Jiangsu Pacific Meinuoke Bio Pharmaceutical.
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
SARS-CoV-2 and COVID-19: SARS-CoV-2 may utilise CD147 as an additional entry receptor to infect host cells . Meplazumab can block this interaction between CD147 and SARS-CoV-2 spike protein.
|Ligand families/groups||Antimalarial ligands|
|HP6H8 | Ketantin®|
|GtoPdb PubChem SID||405560467|